157 related articles for article (PubMed ID: 36758378)
1. DNGR-1-mediated cross-presentation of dead cell-associated antigens.
Henry CM; Castellanos CA; Reis e Sousa C
Semin Immunol; 2023 Mar; 66():101726. PubMed ID: 36758378
[TBL] [Abstract][Full Text] [Related]
2. SYK ubiquitination by CBL E3 ligases restrains cross-presentation of dead cell-associated antigens by type 1 dendritic cells.
Henry CM; Castellanos CA; Buck MD; Giampazolias E; Frederico B; Cardoso A; Rogers NC; Schulz O; Lee S; Canton J; Faull P; Snijders AP; Mohapatra B; Band H; Reis E Sousa C
Cell Rep; 2023 Dec; 42(12):113506. PubMed ID: 38019655
[TBL] [Abstract][Full Text] [Related]
3. Cross-presentation of dead-cell-associated antigens by DNGR-1
Balam S; Kesselring R; Eggenhofer E; Blaimer S; Evert K; Evert M; Schlitt HJ; Geissler EK; van Blijswijk J; Lee S; Reis e Sousa C; Brunner SM; Fichtner-Feigl S
Eur J Immunol; 2020 Dec; 50(12):2041-2054. PubMed ID: 32640051
[TBL] [Abstract][Full Text] [Related]
4. Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity.
Giampazolias E; Schulz O; Lim KHJ; Rogers NC; Chakravarty P; Srinivasan N; Gordon O; Cardoso A; Buck MD; Poirier EZ; Canton J; Zelenay S; Sammicheli S; Moncaut N; Varsani-Brown S; Rosewell I; Reis e Sousa C
Cell; 2021 Jul; 184(15):4016-4031.e22. PubMed ID: 34081922
[TBL] [Abstract][Full Text] [Related]
5. The receptor DNGR-1 signals for phagosomal rupture to promote cross-presentation of dead-cell-associated antigens.
Canton J; Blees H; Henry CM; Buck MD; Schulz O; Rogers NC; Childs E; Zelenay S; Rhys H; Domart MC; Collinson L; Alloatti A; Ellison CJ; Amigorena S; Papayannopoulos V; Thomas DC; Randow F; Reis e Sousa C
Nat Immunol; 2021 Feb; 22(2):140-153. PubMed ID: 33349708
[TBL] [Abstract][Full Text] [Related]
6. The DC receptor DNGR-1 mediates cross-priming of CTLs during vaccinia virus infection in mice.
Iborra S; Izquierdo HM; Martínez-López M; Blanco-Menéndez N; Reis e Sousa C; Sancho D
J Clin Invest; 2012 May; 122(5):1628-43. PubMed ID: 22505455
[TBL] [Abstract][Full Text] [Related]
7. DNGR-1 is dispensable for CD8+ T-cell priming during respiratory syncytial virus infection.
Durant LR; Pereira C; Boakye A; Makris S; Kausar F; Goritzka M; Johansson C
Eur J Immunol; 2014 Aug; 44(8):2340-8. PubMed ID: 24777856
[TBL] [Abstract][Full Text] [Related]
8. The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice.
Zelenay S; Keller AM; Whitney PG; Schraml BU; Deddouche S; Rogers NC; Schulz O; Sancho D; Reis e Sousa C
J Clin Invest; 2012 May; 122(5):1615-27. PubMed ID: 22505458
[TBL] [Abstract][Full Text] [Related]
9. DNGR-1, a Dendritic Cell-Specific Sensor of Tissue Damage That Dually Modulates Immunity and Inflammation.
Cueto FJ; Del Fresno C; Sancho D
Front Immunol; 2019; 10():3146. PubMed ID: 32117205
[TBL] [Abstract][Full Text] [Related]
10. Myosin II Synergizes with F-Actin to Promote DNGR-1-Dependent Cross-Presentation of Dead Cell-Associated Antigens.
Schulz O; Hanč P; Böttcher JP; Hoogeboom R; Diebold SS; Tolar P; Reis e Sousa C
Cell Rep; 2018 Jul; 24(2):419-428. PubMed ID: 29996102
[TBL] [Abstract][Full Text] [Related]
11. DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
Cueto FJ; Del Fresno C; Brandi P; Combes AJ; Hernández-García E; Sánchez-Paulete AR; Enamorado M; Bromley CP; Gomez MJ; Conde-Garrosa R; Mañes S; Zelenay S; Melero I; Iborra S; Krummel MF; Sancho D
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 33980589
[TBL] [Abstract][Full Text] [Related]
12. Efficient and versatile manipulation of the peripheral CD4+ T-cell compartment by antigen targeting to DNGR-1/CLEC9A.
Joffre OP; Sancho D; Zelenay S; Keller AM; Reis e Sousa C
Eur J Immunol; 2010 May; 40(5):1255-65. PubMed ID: 20333625
[TBL] [Abstract][Full Text] [Related]
13. cDC1 prime and are licensed by CD4
Ferris ST; Durai V; Wu R; Theisen DJ; Ward JP; Bern MD; Davidson JT; Bagadia P; Liu T; Briseño CG; Li L; Gillanders WE; Wu GF; Yokoyama WM; Murphy TL; Schreiber RD; Murphy KM
Nature; 2020 Aug; 584(7822):624-629. PubMed ID: 32788723
[TBL] [Abstract][Full Text] [Related]
14. Enhancing the immunogenicity of cancer vaccines by harnessing CLEC9A.
Lahoud MH; Radford KJ
Hum Vaccin Immunother; 2022 Dec; 18(1):1873056. PubMed ID: 33625943
[TBL] [Abstract][Full Text] [Related]
15. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.
Sancho D; Joffre OP; Keller AM; Rogers NC; Martínez D; Hernanz-Falcón P; Rosewell I; Reis e Sousa C
Nature; 2009 Apr; 458(7240):899-903. PubMed ID: 19219027
[TBL] [Abstract][Full Text] [Related]
16. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
[TBL] [Abstract][Full Text] [Related]
17. Loss of secreted gelsolin enhances response to anticancer therapies.
Lim KHJ; Giampazolias E; Schulz O; Rogers NC; Wilkins A; Sahai E; Strid J; Reis e Sousa C
J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36162919
[TBL] [Abstract][Full Text] [Related]
18. Structure of the Complex of F-Actin and DNGR-1, a C-Type Lectin Receptor Involved in Dendritic Cell Cross-Presentation of Dead Cell-Associated Antigens.
Hanč P; Fujii T; Iborra S; Yamada Y; Huotari J; Schulz O; Ahrens S; Kjær S; Way M; Sancho D; Namba K; Reis e Sousa C
Immunity; 2015 May; 42(5):839-849. PubMed ID: 25979418
[TBL] [Abstract][Full Text] [Related]
19. The levels of DNGR-1 and its ligand-bearing cells were altered after human and simian immunodeficiency virus infection.
Yao WR; Li D; Yu L; Wang FJ; Xing H; Yang GB
Immunol Res; 2017 Aug; 65(4):869-879. PubMed ID: 28478499
[TBL] [Abstract][Full Text] [Related]
20. Optimal Generation of Tissue-Resident but Not Circulating Memory T Cells during Viral Infection Requires Crosspriming by DNGR-1
Iborra S; Martínez-López M; Khouili SC; Enamorado M; Cueto FJ; Conde-Garrosa R; Del Fresno C; Sancho D
Immunity; 2016 Oct; 45(4):847-860. PubMed ID: 27692611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
